Mirae Asset Global Investments
FDMT icon

Mirae Asset Global Investments’s 4D Molecular Therapeutics FDMT Stock Holding History

Mirae Asset Global Investments’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.1K Sell
2,338
-323
-12% -$3.15K ﹤0.01% 1431
2026
Q1 		$24.8K Sell
2,661
-115
-4% -$1K ﹤0.01% 1407
2025
Q4 		$20.8K Buy
2,776
+970
+54% +$9.84K ﹤0.01% 1532
2025
Q3 		$15.7K Buy
1,806
+16
+0.9% +$96 ﹤0.01% 1525
2025
Q2 		$6.64K Buy
1,790
+257
+17% +$903 ﹤0.01% 1529
2025
Q1 		$5.57K Sell
1,533
-7
-0.5% -$33 ﹤0.01% 1509
2024
Q4 		$8.55K Sell
1,540
-340
-18% -$2.67K ﹤0.01% 1531
2024
Q3 		$20.4K Buy
1,880
+336
+22% +$5.58K ﹤0.01% 1431
2024
Q2 		$32.3K Sell
1,544
-18,554
-92% -$465K ﹤0.01% 1320
2024
Q1 		$430K Sell
20,098
-1,514
-7% -$38.6K ﹤0.01% 1969
2023
Q4 		$438K Buy
21,612
+2,700
+14% +$35.5K ﹤0.01% 2027
2023
Q3 		$241K Sell
18,912
-1,378
-7% -$23K ﹤0.01% 2229
2023
Q2 		$365K Buy
20,290
+466
+2% +$8.58K ﹤0.01% 2093
2023
Q1 		$341K Buy
19,824
+5,084
+34% +$98.9K ﹤0.01% 2104
2022
Q4 		$327K Buy
14,740
+2,189
+17% +$33.8K ﹤0.01% 2106
2022
Q3 		$100K Buy
+12,551
New +$114K ﹤0.01% 2505
2021
Q1 		– Sell
-12,000
Closed -$498K – 1552
2020
Q4 		$498K Buy
+12,000
New +$495K ﹤0.01% 1317

Other funds holding FDMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Mirae Asset Global Investments's FDMT Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its 4D Molecular Therapeutics (FDMT) stake by 12% in Q2 2026, selling an estimated $3.15K and leaving 2,338 shares worth $31.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1431.

Mirae Asset Global Investments first reported a position in FDMT in Q4 2020 and has held it in 17 quarters since. The position peaked at $498K in Q4 2020. 50 funds tracked by Wall St. Rank hold FDMT as of Q2 2026.

  • Mirae Asset Global Investments held 2,338 shares of 4D Molecular Therapeutics worth $31.1K as of Q2 2026.
  • Mirae Asset Global Investments sold 323 4D Molecular Therapeutics shares in Q2 2026, an estimated $3.15K.
  • 4D Molecular Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1431 holding.
  • Mirae Asset Global Investments first reported a position in 4D Molecular Therapeutics in Q4 2020 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's 4D Molecular Therapeutics position peaked at $498K in Q4 2020.
  • 50 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.